T-Cell Neoplasm
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms (NCT04858256) | University of Michigan Rogel Cancer Center | 2023-03-29 |
Track T-Cell Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.